BlogChain post

Sign inSign up

🧬 GLP-1 Series: Could GLP-1 drugs help people with peripheral artery disease (PAD)?

PendingCheck this stamp

PAD reduces blood flow to the legs and can cause pain while walking.

Here’s what the research shows:

• STRIDE: Semaglutide improved walking capacity in people with PAD and type 2 diabetes.

• STARDUST: A small study explored whether liraglutide could improve blood flow in the legs.

• LEADER / SUSTAIN-6: PAD subgroup analyses explored cardiovascular benefits, but did not establish protection against limb complications.

The key question: Can GLP-1 drugs prevent amputations or other serious leg complications?

Improved walking capacity is promising. Whether GLP-1 drugs prevent major limb events remains uncertain.

#HeartHealth #PAD #GLP1

AI-assisted, human reviewedAI helped with the content, but the human substantially created, edited, or directed the final result and reviewed it before publishing.

This is not medical advice. Check with a doctor before acting on anything you read here.

Cite this article

Chayakrit Krittanawong, MD, FACC, FAHA, FSCAI. 🧬 GLP-1 Series: Could GLP-1 drugs help people with peripheral artery disease (PAD)?. Vitahash. 2026. STAMP-2026-1028-P5XRPF4O

0 comments

You need an account to comment. Sign in or sign up.

Loading comments.